Get the Stockscreener App
2.97
0.68%
0.02
After Hours:
2.98
0.010
+0.34%
Atea Pharmaceuticals Inc Stock (AVIR) Forecast
The Atea Pharmaceuticals Inc (AVIR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.34, representing a +382.72% increase from the current price of $2.97. The highest analyst price target is $14.18, and the lowest is $14.49.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AVIR Price Target
Average 11.52
(+287.80% Upside)
Is Atea Pharmaceuticals Inc (AVIR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.05 | Neutral |
| STOCH(9,6) | 81.64 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0175 | Buy |
| ADX(14) | 16.61 | Neutral |
| William %R | -11.97 | Sell |
| CCI(14) | 79.48 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.8815
Buy
|
2.8907
Buy
|
| MA20 |
2.8238
Buy
|
2.863
Buy
|
| MA50 |
2.8855
Buy
|
2.8954
Buy
|
| MA100 |
2.9973
Sell
|
2.9937
Sell
|
| MA200 |
3.2273
Sell
|
3.1857
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, AVIR could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on AVIR, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 56.05 indicates that AVIR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.64 indicates that AVIR is oversold. This means that AVIR price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that AVIR is oversold. This suggests that AVIR price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.61 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 79.48 indicates that AVIR is still overbought but not to an extreme extent.
Long-term AVIR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atea Pharmaceuticals Inc financial reports and earnings history, Atea Pharmaceuticals Inc (AVIR) stock could reach $30.41 by 2030, $14.82 by 2040 and $116.68 by 2050. See the projected annual prices until 2050 of the Atea Pharmaceuticals Inc stock below:
- Atea Pharmaceuticals Inc (AVIR) is expected to reach an average price of $30.68 in 2035, with a high prediction of $32.16 and a low estimate of $30.83. This indicates an $933.10% rise from the last recorded price of $2.97.
- Atea Pharmaceuticals Inc (AVIR) stock is projected to chart a bullish course in 2040, with an average price target of $13.76, representing an $363.43% surge from its current level. The forecast ranges from a conservative $14.11 to a sky-high $14.82.
- Our analysts predict Atea Pharmaceuticals Inc (AVIR) to jump 3,818% by 2045, soaring from $116.58 to an average price of $116.38, potentially reaching $117.21. While $116.58 is the low estimate, the potential upside is significant.
- Atea Pharmaceuticals Inc (AVIR) stock is expected to climb by 2050, reaching an average of $113.26, a $3,714% jump from its current level. However, a wide range of estimates exists, with high and low targets of $116.68 and $113.42, respectively, highlighting the market's uncertainty.
Atea Pharmaceuticals Inc Stock (AVIR) Year by Year Forecast
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2025
Atea Pharmaceuticals Inc Stock (AVIR) is expected to reach an average price of $11.91 in 2025, with a high prediction of $23.48 and a low estimate of $0.3337. This indicates an +300.88% rise from the last recorded price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $13.45 | $14.49 | $14.18 | +352.93% |
| August, 2025 | $14.18 | $13.05 | $13.55 | +377.51% |
| September, 2025 | $14.12 | $14.29 | $14.37 | +375.49% |
| October, 2025 | $14.56 | $14.18 | $14.14 | +390.31% |
| November, 2025 | $12.57 | $13.04 | $13.79 | +323.31% |
| December, 2025 | $13.27 | $12.60 | $12.81 | +346.89% |
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2026
The predicted value for Atea Pharmaceuticals Inc (AVIR) in 2026 is set at an average of $10.67. Estimates vary from a peak of $12.68 to a trough of $8.6631, indicating an +259.36% surge from the present price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.44 | $11.47 | $12.68 | +251.61% |
| February, 2026 | $11.60 | $10.56 | $10.59 | +290.67% |
| March, 2026 | $9.6729 | $10.55 | $10.55 | +225.69% |
| April, 2026 | $8.5231 | $8.8231 | $8.883 | +186.97% |
| May, 2026 | $8.9632 | $8.6631 | $8.6632 | +201.79% |
| June, 2026 | $10.20 | $9.1832 | $9.7733 | +243.55% |
| July, 2026 | $9.2435 | $9.4635 | $10.14 | +211.23% |
| August, 2026 | $10.03 | $9.3035 | $9.8736 | +237.83% |
| September, 2026 | $9.4838 | $9.7738 | $9.8436 | +219.32% |
| October, 2026 | $8.6539 | $8.8939 | $9.1038 | +191.38% |
| November, 2026 | $8.824 | $8.674 | $8.5839 | +197.10% |
| December, 2026 | $9.0441 | $8.884 | $8.9541 | +204.52% |
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atea Pharmaceuticals Inc (AVIR) is $5.2595, with a high forecast of $8.6142 and a low forecast of $1.9048. This indicates an +77.09% increase from the last price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.4543 | $8.5893 | $8.6142 | +184.66% |
| February, 2027 | $7.9944 | $8.1444 | $8.1743 | +169.17% |
| March, 2027 | $6.1945 | $6.5045 | $7.7494 | +108.57% |
| April, 2027 | $6.4347 | $6.4311 | $6.2297 | +116.65% |
| May, 2027 | $6.2548 | $6.1747 | $6.2538 | +110.60% |
| June, 2027 | $5.6949 | $5.7049 | $6.0548 | +91.75% |
| July, 2027 | $5.305 | $5.385 | $5.45 | +78.62% |
| August, 2027 | $4.9352 | $5.0152 | $5.0851 | +66.17% |
| September, 2027 | $4.4153 | $4.4103 | $4.7552 | +48.66% |
| October, 2027 | $3.6754 | $3.8454 | $4.0953 | +23.75% |
| November, 2027 | $3.2256 | $3.2256 | $3.5155 | +8.60% |
| December, 2027 | $1.4657 | $1.9048 | $2.8856 | -50.65% |
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2028
In 2028, Atea Pharmaceuticals Inc (AVIR) is projected to reach an average price of $18.72, with a high projection of $37.43 and a low estimate of $0.0138. This indicates an +530.41% rise from the last price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9058 | $1.1058 | $1.2307 | -69.50% |
| February, 2028 | $0.5759 | $0.5259 | $0.4059 | -80.61% |
| March, 2028 | $0.2161 | $0.2655 | $0.321 | -92.72% |
| April, 2028 | $26.47 | $0.0138 | $25.05 | +791.25% |
| May, 2028 | $29.97 | $26.68 | $26.17 | +909.10% |
| June, 2028 | $16.36 | $23.80 | $28.83 | +450.86% |
| July, 2028 | $15.74 | $5.2733 | $17.16 | +429.94% |
| August, 2028 | $4.0189 | $1.3989 | $37.43 | +35.32% |
| September, 2028 | $6.8287 | $0.4588 | $24.05 | +129.92% |
| October, 2028 | $17.47 | $1.7864 | $8.7186 | +488.27% |
| November, 2028 | $32.16 | $29.42 | $29.85 | +982.89% |
| December, 2028 | $27.73 | $29.04 | $30.61 | +833.74% |
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2029
The 2029 price forecast for Atea Pharmaceuticals Inc Stock (AVIR) is $21.95 on average, with a high prediction of $36.70 and a low estimate of $7.203. This represents an +639.17% increase from the previous price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $25.13 | $27.86 | $27.57 | +746.21% |
| February, 2029 | $19.54 | $22.44 | $23.72 | +558.00% |
| March, 2029 | $19.56 | $19.21 | $18.14 | +558.68% |
| April, 2029 | $5.1357 | $7.203 | $18.90 | +72.92% |
| May, 2029 | $35.01 | $7.5532 | $33.59 | +1,079% |
| June, 2029 | $36.69 | $35.05 | $36.70 | +1,135% |
| July, 2029 | $34.63 | $35.43 | $36.27 | +1,066% |
| August, 2029 | $35.64 | $34.79 | $35.59 | +1,100% |
| September, 2029 | $35.48 | $35.05 | $35.04 | +1,095% |
| October, 2029 | $33.02 | $34.62 | $34.71 | +1,012% |
| November, 2029 | $32.40 | $32.26 | $32.34 | +991.08% |
| December, 2029 | $32.51 | $32.38 | $32.00 | +994.45% |
Atea Pharmaceuticals Inc Stock (AVIR) Price Forecast for 2030
Atea Pharmaceuticals Inc Stock (AVIR) is expected to reach an average price of $25.88 in 2030, with a high forecast of $30.41 and a low forecast of $21.36. This signifies an +771.44% surge from the last price of $2.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $28.93 | $29.24 | $30.41 | +873.92% |
| February, 2030 | $28.59 | $28.80 | $28.70 | +862.48% |
| March, 2030 | $26.65 | $26.81 | $28.12 | +797.17% |
| April, 2030 | $25.37 | $25.47 | $26.07 | +754.08% |
| May, 2030 | $25.60 | $25.47 | $25.17 | +761.84% |
| June, 2030 | $26.02 | $26.15 | $25.78 | +775.99% |
| July, 2030 | $24.80 | $24.42 | $25.27 | +734.92% |
| August, 2030 | $24.13 | $24.36 | $24.60 | +712.37% |
| September, 2030 | $23.08 | $23.71 | $23.72 | +677.02% |
| October, 2030 | $21.96 | $22.06 | $22.65 | +639.32% |
| November, 2030 | $21.88 | $21.79 | $21.55 | +636.64% |
| December, 2030 | $20.74 | $21.36 | $21.60 | +598.26% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):